137 related articles for article (PubMed ID: 11368411)
1. Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues.
Silva AL; Diamond J; Silva MR; Passos-Coelho JL
Breast Cancer Res Treat; 2001 Mar; 66(1):59-66. PubMed ID: 11368411
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
3. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
[TBL] [Abstract][Full Text] [Related]
4. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
Silva AL; Tomé MJ; Correia AE; Passos-Coelho JL
Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
[TBL] [Abstract][Full Text] [Related]
5. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression.
Lassmann S; Bauer M; Rosenberg R; Nekarda H; Soong R; Rüger R; Höfler H; Werner M
Int J Colorectal Dis; 2004 Mar; 19(2):87-94. PubMed ID: 13680284
[TBL] [Abstract][Full Text] [Related]
6. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.
Vlems FA; Diepstra JH; Cornelissen IM; Ruers TJ; Ligtenberg MJ; Punt CJ; van Krieken JH; Wobbes T; van Muijen GN
Mol Pathol; 2002 Jun; 55(3):156-63. PubMed ID: 12032226
[TBL] [Abstract][Full Text] [Related]
7. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.
Schuster R; Max N; Mann B; Heufelder K; Thilo F; Gröne J; Rokos F; Buhr HJ; Thiel E; Keilholz U
Int J Cancer; 2004 Jan; 108(2):219-27. PubMed ID: 14639606
[TBL] [Abstract][Full Text] [Related]
8. CK20 gene expression: technical limits for the detection of circulating tumor cells.
Champelovier P; Mongelard F; Seigneurin D
Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer.
Huang P; Wang J; Guo Y; Xie W
J Cancer Res Clin Oncol; 2003 Mar; 129(3):192-8. PubMed ID: 12684893
[TBL] [Abstract][Full Text] [Related]
11. Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR.
Hu XC; Chow LW
Oncology; 2000 Sep; 59(3):217-22. PubMed ID: 11053989
[TBL] [Abstract][Full Text] [Related]
12. Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes.
Soong R; Beyser K; Basten O; Kalbe A; Rueschoff J; Tabiti K
Clin Cancer Res; 2001 Nov; 7(11):3423-9. PubMed ID: 11705858
[TBL] [Abstract][Full Text] [Related]
13. Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR.
Schmitz-Winnenthal FH; Weckauf H; Haufe S; Hinz U; Z'graggen K; Klar E; Büchler MW; Weber T
Surgery; 2003 Dec; 134(6):964-71; discussion 971-2. PubMed ID: 14668729
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen.
Kodera Y; Nakanishi H; Ito S; Yamamura Y; Fujiwara M; Koike M; Hibi K; Ito K; Tatematsu M; Nakao A
Gastric Cancer; 2005; 8(3):142-8. PubMed ID: 16086116
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR).
Hu XC; Chow LW
Eur J Surg Oncol; 2000 Sep; 26(6):530-5. PubMed ID: 11034801
[TBL] [Abstract][Full Text] [Related]
16. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
17. Detection of cancer cells in the peripheral blood of gastric cancer patients.
Ikeguchi M; Ohro S; Maeda Y; Fukuda K; Yamaguchi K; Shirai H; Kondo A; Tsujitani S; Kaibara N
Int J Mol Med; 2003 Feb; 11(2):217-21. PubMed ID: 12525881
[TBL] [Abstract][Full Text] [Related]
18. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
[TBL] [Abstract][Full Text] [Related]
20. Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity.
Lassmann S; Bauer M; Soong R; Schreglmann J; Tabiti K; Nährig J; Rüger R; Höfler H; Werner M
J Pathol; 2002 Oct; 198(2):198-206. PubMed ID: 12237879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
